Kim Kelderman Power

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Minneapolis, MN
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Kim Kelderman Power

Form 4 holding Chief Executive Officer, Director

BIO-TECHNE Corp

Security class
Restricted Stock Units
Shares / value
93,582
Estimated value
$6,703,278
Report date
17 Aug 2026
Price
$71.63
Ownership
Direct
Underlying class
Common Stock
Underlying amount
93,582
Form 4 holding Chief Executive Officer, Director

BIO-TECHNE Corp

Security class
Stock Options (Right to Buy)
Shares / value
90,441
Estimated value
$6,478,288
Report date
17 Aug 2026
Price
$71.63
Ownership
Direct
Underlying class
Common Stock
Underlying amount
90,441
Form 4 holding Chief Executive Officer, Director

BIO-TECHNE Corp

Security class
Common Stock
Shares / value
82,762
Estimated value
$5,847,135
Report date
17 Aug 2026
Price
$70.65
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

BIO-TECHNE Corp

Security class
Performance Restricted Stock Units
Shares / value
70,708
Estimated value
$5,064,814
Report date
17 Aug 2026
Price
$71.63
Ownership
Direct
Underlying class
Common Stock
Underlying amount
70,708
Form 4 holding Chief Executive Officer, Director

BIO-TECHNE Corp

Security class
Stock Option (Right to Buy)
Shares / value
25,944
Estimated value
$1,858,368
Report date
17 Aug 2026
Price
$71.63
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,944
Form 4 holding Chief Executive Officer, Director

BIO-TECHNE Corp

Security class
Performance Stock Options (Right to Buy)
Shares / value
1,621
Estimated value
$1,833,014
Report date
15 Aug 2026
Price
$70.65
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,945
Form 4 holding Director

CONMED Corp

Security class
Options To Purchase Common Stock
Shares / value
6,227
Estimated value
Report date
08 Sep 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CONMED Corp

Security class
RSUs (Restricted Stock Units)
Shares / value
5,772
Estimated value
Report date
01 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Kim Kelderman Power

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .